YKL-40 and MMP-9 as Serum Markers for Patients with Primary Central Nervous System Lymphoma

OBJECTIVE: To evaluate YKL-40 and MMP-9 proteins as tumor biomarkers in serum samples from patients with primary central nervous system lymphoma (PCNSL). METHODS: In this prospective longitudinal study, serum samples from consecutive patients with histologically confirmed PCNSL were collected concur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Neurol
Autores principales: Hottinger, Andreas F., Iwamoto, Fabio M., Karimi, Sasan, Riedel, Elyn, Dantis, Jocelynn, Park, Joseph, Panageas, Katherine S., Lassman, Andrew B., Abrey, Lauren E., Fleisher, Martin, Holland, Eric C., DeAngelis, Lisa M., Hormigo, Adília
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7295085/
https://ncbi.nlm.nih.gov/pubmed/21391238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22360
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares